GENB · TickerCove

GENBGenerate Biomedicines, Inc.Healthcare · Biotechnologyas of 2026-09-16

Horizon

Issued 2026-09-16 at $15.68 · now $15.68 (2026-09-16, +0.0% since)

Based on its own history, a month from the 2026-09-16 close, GENB has typically landed between $12.60 and $22.05 — a range of −19.6% to +40.6% from the issuance price $15.68.

Range of outcomes in historically similar periods — not a price prediction. Ranges are scored publicly on /methodology.

Actual close
Typical path (median)
Middle 50% of outcomes
90% range

118 overlapping 1 month windows · 2026-02-27 – 2026-08-17 · basis climatology · forecast (batch).

The cone is anchored at the 2026-09-16 issuance close ($15.68) — the price the forecast resolves against on 2026-10-15, not the latest close. The drawn path shape is illustrative (bands widen with √t); every labeled number is real — the anchor, the scored batch p90/IQR endpoints, and the typical move.

52-week range$15.68 · 49% of range

$11.21 low$20.38 high

Trailing 52 weeks to 2026-09-16 — factual context, not a signal.

Distribution ranges onlyiThis name has too little trading history to publish a calibrated probability, so we show its distribution ranges only — no directional call. Its record is still building.

No directional probability — ranges below.

Distribution · month iiThe price-anchored range: typical move (median), and the p90 downside/upside — 90% of similar periods stayed inside these. Ranges, not a prediction of direction.

+5.5%

typical move · IQR 17.5%

−19.6%worst (p90)+40.6%best (p90)

Insider convictioniOpen-market common-stock purchases by company insiders in the last 90 days (grants and option exercises excluded). Historical tendency, not advice — detail below.

conviction buys

0 open-market sales

Congress disclosuresiRecent disclosed congressional trades for this company. Purchase clusters (≥2 members buying within 90 days) historically preceded a modestly higher forward return (+32 bp/mo in 2022–2026, +45 bp/mo in 2015–2021) — a descriptive tendency, not a forecast input. Detail below.

0 buys · 0 sells · 0 members

cluster tilt persisted, ~halved after 2021

Where GENB has typically landed a month from the 2026-09-16 close of $15.68 — the range is history, not a prediction.

now $15.68 (+0.0%)
typical $16.54 (+5.5%)
middle 50% $15.17–$17.91
90% range $12.6–$22.05

Actual 1-month windows behind the coneiEvery overlapping 1-month window in this security's own price history was ranked by realized return; shown are the 3 worst and 3 best of 118 windows spanning 2026-02-27 to 2026-09-16. Not cherry-picked — these are the extremes of the full sample. Max drop / max rise are the deepest and highest points reached within each window. See /methodology.

Start	Return	Max drop	Max rise
3 worst
2026-05-13	−23.7%	−26.2%	+0.0%
2026-06-29	−22.6%	−22.6%	+3.0%
2026-06-26	−20.2%	−20.2%	+5.7%
3 best
2026-07-27	+49.0%	−4.4%	+49.0%
2026-06-02	+45.4%	+0.0%	+45.4%
2026-07-24	+32.2%	−2.4%	+32.2%

118 overlapping windows · 2026-02-27 – 2026-09-16 · not cherry-picked

Reported insider & political trades

Every Form 4 the people closest to this company have filed with the SEC — plotted against the share price, aggregated by month, and shown with the gap between when each trade happened and when it was disclosed. A public record, not advice.

Date	Person	Role	Action	Shares @ price	Value	Ownership Δ	vs S&P 1m	vs S&P 6m	Owned after	Filing
2026-09-01	ARNOLD FRANCES	director	Sale	1,000 @ $16.00	$16K	−0.4% of holding	not yet — horizon still open	not yet — horizon still open	231,472	Form 4 · filed 2 days after the trade
2026-03-04	Nally Michael	director	Purchase	20,000 @ $12.00	$240K	+3.6% of holding	+22.8%	+28.3%	572,707	Form 4 · filed 2 days after the trade
2026-03-02	AFEYAN NOUBAR	director	Purchase	1,562,500 @ $16.00	$25.0M	+11.4% of holding	+7.7%	+13.1%	15,264,724	Form 4 · filed same day
2026-03-02	AFEYAN NOUBAR	director	Purchase	1,562,500 @ $16.00	$25.0M	+56.3% of holding	+7.7%	+13.1%	4,340,252	Form 4 · filed same day
2026-03-02	AFEYAN NOUBAR	director	Purchase	1,562,500 @ $16.00	$25.0M	ownership Δ n/a	+7.7%	+13.1%	1,562,500	Form 4 · filed same day
2026-03-02	AFEYAN NOUBAR	director	Purchase	1,562,500 @ $16.00	$25.0M	+56.3% of holding	+7.7%	+13.1%	4,340,252	Form 4 · filed same day
2026-03-02	AFEYAN NOUBAR	director	Purchase	1,562,500 @ $16.00	$25.0M	+11.4% of holding	+7.7%	+13.1%	15,264,724	Form 4 · filed same day
2026-03-02	AFEYAN NOUBAR	director	Purchase	1,562,500 @ $16.00	$25.0M	ownership Δ n/a	+7.7%	+13.1%	1,562,500	Form 4 · filed same day
2026-03-02	Mendillo Jane L	director	Purchase	1,500 @ $16.00	$24K	ownership Δ n/a	+7.7%	+13.1%	1,500	Form 4 · filed same day
2026-03-02	Silvers Jason	officer	Purchase	1,000 @ $16.00	$16K	ownership Δ n/a	+7.7%	+13.1%	1,000	Form 4 · filed same day
2026-03-02	Silvers Jason	officer	Purchase	500 @ $16.00	$8K	ownership Δ n/a	+7.7%	+13.1%	500	Form 4 · filed same day
2026-03-02	Grous Beth	officer	Purchase	300 @ $16.00	$5K	ownership Δ n/a	+7.7%	+13.1%	300	Form 4 · filed same day

The vs-S&P columns are a labeled look-back on what the stock did after each filing, measured against the index over the same window. Descriptive history, not a claim about the person or a reason to trade.

124 award / exercise / gift records — not counted as purchases

Awards, option exercises, gifts and tax-withholding disposals are shown separately and never counted as open-market purchases or sales — they carry no conviction information.

Date	Person	Role	Action	Shares	Owned after	Filing
2026-03-02	AFEYAN NOUBAR	director	Conversion	1,265,822	0	Form 4
2026-03-02	AFEYAN NOUBAR	director	Conversion	2,953,586	0	Form 4
2026-03-02	AFEYAN NOUBAR	director	Conversion	2,109,704	0	Form 4
2026-03-02	AFEYAN NOUBAR	director	Conversion	2,531,644	0	Form 4
2026-03-02	Nally Michael	director	Conversion	1,000,000	0	Form 4
2026-03-02	AFEYAN NOUBAR	director	Conversion	17,016,215	0	Form 4
2026-03-02	AFEYAN NOUBAR	director	Conversion	18,483,785	0	Form 4
2026-03-02	AFEYAN NOUBAR	director	Conversion	1,500,000	0	Form 4
2026-03-02	AFEYAN NOUBAR	director	Conversion	843,881	0	Form 4
2026-03-02	AFEYAN NOUBAR	director	Conversion	1,265,822	0	Form 4
2026-03-02	AFEYAN NOUBAR	director	Conversion	2,953,586	0	Form 4
2026-03-02	AFEYAN NOUBAR	director	Conversion	2,109,704	0	Form 4
2026-03-02	AFEYAN NOUBAR	director	Conversion	2,531,644	0	Form 4
2026-03-02	Bancel Stephane	director	Conversion	1,100,000	0	Form 4
2026-03-02	AFEYAN NOUBAR	director	Conversion	18,483,785	0	Form 4
2026-03-02	AFEYAN NOUBAR	director	Conversion	17,016,215	0	Form 4
2026-03-02	AFEYAN NOUBAR	director	Conversion	1,500,000	0	Form 4
2026-03-02	AFEYAN NOUBAR	director	Conversion	843,881	0	Form 4
2026-03-02	AFEYAN NOUBAR	director	Conversion	2,777,752	2,777,752	Form 4
2026-03-02	AFEYAN NOUBAR	director	Conversion	12,723,940	12,723,940	Form 4
2026-03-02	AFEYAN NOUBAR	director	Conversion	13,702,224	13,702,224	Form 4
2026-03-02	AFEYAN NOUBAR	director	Conversion	987,491	987,491	Form 4
2026-03-02	AFEYAN NOUBAR	director	Conversion	2,777,752	2,777,752	Form 4
2026-03-02	AFEYAN NOUBAR	director	Conversion	2,777,752	2,777,752	Form 4
2026-03-02	AFEYAN NOUBAR	director	Conversion	12,723,940	12,723,940	Form 4
2026-03-02	AFEYAN NOUBAR	director	Conversion	13,702,224	13,702,224	Form 4
2026-03-02	AFEYAN NOUBAR	director	Conversion	987,491	987,491	Form 4
2026-03-02	AFEYAN NOUBAR	director	Conversion	2,777,752	2,777,752	Form 4
2026-03-02	AFEYAN NOUBAR	director	Conversion	2,777,752	2,777,752	Form 4
2026-03-02	Nally Michael	director	Conversion	658,327	1,316,654	Form 4
2026-03-02	AFEYAN NOUBAR	director	Conversion	12,723,940	12,723,940	Form 4
2026-03-02	AFEYAN NOUBAR	director	Conversion	13,702,224	13,702,224	Form 4
2026-03-02	AFEYAN NOUBAR	director	Conversion	987,491	987,491	Form 4
2026-03-02	AFEYAN NOUBAR	director	Conversion	2,777,752	2,777,752	Form 4
2026-03-02	AFEYAN NOUBAR	director	Conversion	2,777,752	2,777,752	Form 4
2026-03-02	AFEYAN NOUBAR	director	Conversion	12,723,940	12,723,940	Form 4
2026-03-02	AFEYAN NOUBAR	director	Conversion	987,491	987,491	Form 4
2026-03-02	AFEYAN NOUBAR	director	Conversion	2,777,752	2,777,752	Form 4
2026-03-02	AFEYAN NOUBAR	director	Conversion	2,777,752	2,777,752	Form 4
2026-03-02	AFEYAN NOUBAR	director	Conversion	13,702,224	13,702,224	Form 4

Source: SEC Form 4 filings. Each row links to its original filing.

Across 2012–2021, stocks where a CEO, C-suite officer, or director had recently made an open-market common-stock purchase ran about +28 bp per month above the universe average (n=34,268 stock-weeks). A historical tendency, not a prediction.

Congressional disclosures

No congressional trades disclosed for this company.

Resolves in i

28d remaining

2026-09-173% elapsed2026-10-15

Logged immutably 2026-09-17; scored automatically on 2026-10-15 — no edits, ever.

Earnings & context analysis

These panels are being prepared. They are generated by multiple language models, checked, and stored before display — never written live for a page view. Until a model panel has been generated and reviewed for a company, nothing is shown here, honestly, rather than a placeholder.

Calibration i

Every forecast is logged when made and scored when the month is up. The record is shown from the day it starts — young and honest.

How scoring works →

Research tool, not investment advice — historical frequencies, not recommendations. A product of Marovel Technologies LLC. Full terms.